Total Health

 

Total Health is the largest provider of free cancer care resources for people who are treating or living with cancer. Our programs arm cancer care teams with the latest research and strategies to improve patient outcomes.

For more info visit our website at Total Health.


 

2020 ASCO Update on HER2+ mCRC: Did Trastuzumab Deruxtecan Demonstrate Activity in Patients With HER2-Expressing Disease Who Are Refractory to Standard Therapies?

0 views
August 20, 2020
Comments 0
Login to view comments. Click here to Login